Lataa...
Time to market for drugs approved in Canada between 2014 and 2018: an observational study
OBJECTIVES: This study examines the length of time between when a patent application is filed in Canada for a new drug and when it is available for patients (time to market) and various components of that time. It also looks at whether various factors explain the time between patent application to N...
Tallennettuna:
| Julkaisussa: | BMJ Open |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8258566/ https://ncbi.nlm.nih.gov/pubmed/34226224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-047557 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|